Reagent kit for the determination of aspartate aminotransferase activity in serum and plasma by the optimized enzymatic kinetic method "ACT UV-KINETICS ABRIS+" as per TU 21.20.23-106-27428909-2023 Composed of: I. Variants of execution: 1. Complete set No 1, consisting of: - reagent 1 - 1 vial (40 ml); - Reagent 2 - 1 vial (10 ml). 2. Complete set No 2, consisting of: - reagent 1 - 1 vial (80 ml); - Reagent 2 - 1 vial (20 ml). 3. Complete set No 3, consisting of: - reagent 1 - 5 vials (16 ml each); - Reagent 2 - 5 vials (4 ml each). 4. Configuration No 4, consisting of: - reagent 1 - 5 vials (40 ml each); - Reagent 2 - 5 vials (10 ml each). 5. Complete set No 5, consisting of: - reagent 1 - 2 vials (200 ml each); - reagent 2 - 2 vials (50 ml each). 6. Configuration No 6, consisting of: - reagent 1 - 3 vials (200 ml each); - reagent 2 - 3 vials (50 ml each). 7. Configuration No 7, consisting of: - reagent 1 - 6 vials (16 ml each); - Reagent 2 - 2 vials (12 ml each). 8. Complete set No 8, consisting of: - reagent 1 - 2 vials (40 ml each); - Reagent 2 - 1 vial (20 ml). 9. Configuration No 9, consisting of: - reagent 1 - 4 vials (40 ml each); - reagent 2 - 2 vials (20 ml each). 10. Configuration No 10, consisting of: - reagent 1 - 2 vials (50 ml each); - Reagent 2 (lyophilizate) - 2 vials. II. Instructions for use. III. Passport. - Roszdravnadzor Registration РЗН 2024/22509

Access comprehensive regulatory information for Reagent kit for the determination of aspartate aminotransferase activity in serum and plasma by the optimized enzymatic kinetic method "ACT UV-KINETICS ABRIS+" as per TU 21.20.23-106-27428909-2023 Composed of: I. Variants of execution: 1. Complete set No 1, consisting of: - reagent 1 - 1 vial (40 ml); - Reagent 2 - 1 vial (10 ml). 2. Complete set No 2, consisting of: - reagent 1 - 1 vial (80 ml); - Reagent 2 - 1 vial (20 ml). 3. Complete set No 3, consisting of: - reagent 1 - 5 vials (16 ml each); - Reagent 2 - 5 vials (4 ml each). 4. Configuration No 4, consisting of: - reagent 1 - 5 vials (40 ml each); - Reagent 2 - 5 vials (10 ml each). 5. Complete set No 5, consisting of: - reagent 1 - 2 vials (200 ml each); - reagent 2 - 2 vials (50 ml each). 6. Configuration No 6, consisting of: - reagent 1 - 3 vials (200 ml each); - reagent 2 - 3 vials (50 ml each). 7. Configuration No 7, consisting of: - reagent 1 - 6 vials (16 ml each); - Reagent 2 - 2 vials (12 ml each). 8. Complete set No 8, consisting of: - reagent 1 - 2 vials (40 ml each); - Reagent 2 - 1 vial (20 ml). 9. Configuration No 9, consisting of: - reagent 1 - 4 vials (40 ml each); - reagent 2 - 2 vials (20 ml each). 10. Configuration No 10, consisting of: - reagent 1 - 2 vials (50 ml each); - Reagent 2 (lyophilizate) - 2 vials. II. Instructions for use. III. Passport. in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number РЗН 2024/22509 and manufactured by NPF ABRIS+ LLC. The device was registered on April 27, 2024.

This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.